Skip to content

Clinical trials

Neoplasms by Site trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms by Site Country / region: Australia Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20131
20141
20151
20162
20174
20192
20201
20214
20222
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting5
Recruiting5
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Hoffmann-La Roche2
Revolution Medicines, Inc.2
Sumitomo Pharma America, Inc.2
Abbott1
Astellas Pharma Global Development, Inc.1
AstraZeneca1
Australian and New Zealand Urogenital and Prostate Cancer Trials Group1
BeiGene USA, Inc.1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms by Site22
Neoplasms20
Carcinoma, Non-Small-Cell Lung8
Lung Diseases8
Lung Neoplasms8
Respiratory Tract Diseases8
Respiratory Tract Neoplasms8
Thoracic Neoplasms7
Bronchial Neoplasms6
Digestive System Neoplasms6

Trials

Showing 76 to 22 of 22. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.